Mallinckrodt changes fiscal year end to calendar year from late-December fiscal year

Keenova Therapeutics plc

Fiscal year end shifts from last Friday of December to December 31, effective prospectively.
No transition report required; change adds 5 operating days in FY2025 and 2 in FY2026.
FY2025 annual report covers Dec 28, 2024 to Dec 31, 2025.
Quarterly periods in FY2026 will have different operating days, affecting comparability.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Keenova Therapeutics plc: Company changed fiscal year end from a 52-53 week year ending on the last Friday of December to a calendar year ending on December 31 (effective 2025-11-07).

Change: fiscal year change
Effective: 2025-11-07

Exact text from the filing

On November 7, 2025, Mallinckrodt plc (the “Company”) determined to change the Company’s fiscal year end from a 52-53 week year ending on the last Friday of December to a calendar year ending on December 31.

View on SEC.gov

241 governance changes filed in the last 30 days. Browse all governance changes →

Source: SEC EDGAR

accession 0001628280-25-050666

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.